NCT04235569View on ClinicalTrials.gov

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

September 1, 2019

Conditions
Mitral Valve Disease
Interventions
DRUG

Warfarin Sodium 5 MG

warfarin sodium 5mg tablets

DRUG

Warfarin Sodium 3 MG

warfarin sodium 3mg tablets

DRUG

Enoxaparin Sodium 100 MG/ML Prefilled Syringe

"Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes.~Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes.~Clexane® Syringes 6,000 IU (60 mg)/0.6 ml solution for injection in pre-filled syringes.~Clexane® Syringes 8,000 IU (80 mg)/0.8 ml solution for injection in pre-filled syringes.~Dose was determined individually for each patient as 1mg/kg every 12 hours."

Trial Locations (1)

11355

The Cardiovascular Hospital, Heliopolis

All Listed Sponsors
lead

Sarah Sabry Hashem

OTHER

NCT04235569 - Warfarin Initiation in Mechanical Mitral Valve Replacement Patients | Biotech Hunter | Biotech Hunter